CompanyGraph
Improve Medical Instruments Co., Ltd.
300030 · SZSE · China
improve-medical.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 3.77: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.03BCNY302.66M · vs all stocks (USD)
Trailing P/E
65.60xvs Medical Instruments & Supplies peers
Revenue (TTM)
470.40MCNY70.19M · vs all stocks (USD)
Profit Margin
6.39%vs Medical Instruments & Supplies peers
Beta
0.4640xvs all stocks
52-Week Change
-15.46%vs all stocks
Market Capitalization
2.03BCNY302.66M · vs all stocks (USD)
Enterprise Value
2.01BCNY299.50M · vs all stocks (USD)
Trailing P/E
65.60xvs Medical Instruments & Supplies peers
Forward P/E
29.82xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
4.31xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.11xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.27xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
20.24xvs Medical Instruments & Supplies peers
Gross Margin
45.39%vs Medical Instruments & Supplies peers
Profit Margin
6.39%vs Medical Instruments & Supplies peers
Operating Margin
15.60%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
4.05%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
4.66%vs Medical Instruments & Supplies peers
Revenue (TTM)
470.40MCNY70.19M · vs all stocks (USD)
Revenue per Share (TTM)
1.61CNYUpdated Sep 20, 2026Quarterly Revenue Growth
3.80%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
204.23MCNY30.48M · vs all stocks (USD)
EBITDA (TTM)
98.82MCNY14.75M · vs all stocks (USD)
Net Income (TTM)
30.08MCNY4.49M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
22.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
149.55MCNY22.32M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
108.61MCNY16.21M · vs all stocks (USD)
5-Year Average Dividend Yield
0.29%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
34.76MCNYFY2025 · Dec 31, 2025Revenue
486.26MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
277.14MCNYFY2025 · Dec 31, 2025Gross Profit
209.12MCNYFY2025 · Dec 31, 2025Operating Income
41.85MCNY6.25M · vs all stocks (USD)
Pre-tax Income
22.72MCNYFY2025 · Dec 31, 2025Income Tax Expense
7.50MCNYFY2025 · Dec 31, 2025Net Income
15.21MCNYFY2025 · Dec 31, 2025EBIT
27.86MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
98.82MCNYFY2025 · Dec 31, 2025Research & Development
23.65MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
49.91MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.05MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.09MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
5.14MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
290.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
290.61MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
15.21MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-683.83KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
177.41MCNYFY2025 · Dec 31, 2025Free Cash Flow
154.86MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
159.20MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
15.21MCNYFY2025 · Dec 31, 2025Other Non-cash Items
7.61MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
141.92MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
12.65MCNYFY2025 · Dec 31, 2025Capital Expenditures
-22.55MCNYFY2025 · Dec 31, 2025Purchase of Investments
-10.00MCNYFY2025 · Dec 31, 2025Sale of Investments
37.52MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
4.98MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
231.40MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-423.07MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-5.50MCNYFY2025 · Dec 31, 2025Other Financing Charges
-3.10MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-200.27MCNYFY2025 · Dec 31, 2025Shares Outstanding
309.19MSharesUpdated Sep 20, 2026Float Shares
208.87MSharesUpdated Sep 20, 2026% Held by Insiders
37.35%vs all stocks
% Held by Institutions
5.04%vs all stocks
Total Cash (MRQ)
149.87MCNY22.36M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.4850CNYUpdated Sep 20, 2026Total Debt (MRQ)
100.05MCNY14.93M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1472xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.51xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
2.11CNYUpdated Sep 20, 2026Total Assets
1.03BCNY153.24M · vs all stocks (USD)
Total Current Assets
423.34MCNYFY2025 · Dec 31, 2025Total Liabilities
371.82MCNYFY2025 · Dec 31, 2025Total Non-current Assets
603.58MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
53.95MCNYFY2025 · Dec 31, 2025Total Current Liabilities
317.87MCNYFY2025 · Dec 31, 2025Cash
159.22MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.09MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
160.32MCNYFY2025 · Dec 31, 2025Accounts Receivable
124.26MCNYFY2025 · Dec 31, 2025Inventory
81.15MCNYFY2025 · Dec 31, 2025Accounts Payable
70.58MCNYFY2025 · Dec 31, 2025Short-term Debt
129.03MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.14MCNYFY2025 · Dec 31, 2025Long-term Debt
24.69MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
5.28MCNYFY2025 · Dec 31, 2025Common Stock (Book)
309.19MCNYFY2025 · Dec 31, 2025Retained Earnings
-136.74MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
655.10MCNY97.75M · vs all stocks (USD)
52-Week Low
5.61CNYUpdated Sep 20, 202652-Week High
9.00CNYUpdated Sep 20, 202652-Week Change
-15.46%vs all stocks
Beta
0.4640xvs all stocks
50-Day MA
6.59CNYUpdated Sep 20, 2026200-Day MA
7.39CNYUpdated Sep 20, 2026Avg 10-Day Volume
5.19MSharesUpdated Sep 20, 2026Avg 30-Day Volume
6.75MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.1000CNYUpdated Sep 20, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Rising Operating Income With Falling Gross Profit and Shrinking Assets
Operating income has risen while gross profit and the asset base both shrank.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.45Profit Margin: 0.06
Financial Health
Altman Z-Score 3.77: safe zoneNotable
Altman Z-Score: 3.77
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Anton Oilfield Services Group
Tier 1ProductionThroughput-Bound ConversionRule
Zhejiang Benli Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Integrated Diagnostics Holdings PLC
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Beijing Jiaoda Signal Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Sichuan Golden Summit Group Joint-stock Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chunbo Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Safety Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleRisk
Shenzhen Increase Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Guangdong Redwall New Materials Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Topfly New Material Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Shanghai Action Education Technology Co., Ltd.
2 interpretationsCash-Flow Ratios ElevatedFCF Ratios Elevated
Xinjiang Machinery Research Institute Co., Ltd.
2 interpretationsCash-Flow Ratios ElevatedFCF Ratios Elevated
Xuzhou Handler Special Vehicle Co., Ltd.
2 interpretationsCash-Flow Ratios ElevatedFCF Ratios Elevated